Weaning Failure in Critically Ill Patients Is Related to the Persistence of Sepsis Inflammation

Anna Kyriakoudi1, Nikoletta Rovina1, Ourania Koltsida1

  • 11st Department of Respiratory Medicine, Medical School, National and Kapodistrian University of Athens and "Sotiria" Chest Disease Hospital, 11527 Athens, Greece.

Abstract

Insights

Sepsis patients on mechanical ventilation have higher rates of spontaneous breathing trial (SBT) failure. Inflammatory markers like IL-18 and IL-18BP indicate a higher risk of weaning failure in these critically ill patients.

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Infectious Disease

Background:

  • Mechanical ventilation (MV) poses weaning challenges for septic patients.
  • Identifying predictors of weaning success is crucial for patient recovery.

Purpose of the Study:

  • To investigate inflammatory biomarkers of sepsis as predictors of spontaneous breathing trial (SBT) success or failure.
  • To assess the role of serum inflammatory mediators in weaning outcomes for ventilated patients.

Main Methods:

  • Sixty-five patients on MV (42 septic, 23 non-septic) underwent SBT.
  • Serum samples were collected pre-SBT, post-SBT (30 min), and 24 hours after SBT.
  • Levels of Interleukin-18 (IL-18), IL-18 Binding Protein (IL-18BP), and Tumor Necrosis Factor (TNF) were measured and correlated with SBT outcomes.

Main Results:

  • Septic patients exhibited a significantly higher SBT failure rate (85%) compared to non-septic patients (15%).
  • Elevated serum IL-18 and TNF levels were independently associated with sepsis.
  • Higher IL-18 and IL-18BP levels were indicative of SBT failure, with IL-18BP negatively associated with the rapid shallow breathing index (RSBI).

Conclusions:

  • Sustained elevated IL-18 and IL-18BP levels predict SBT failure in sepsis survivors.
  • Persistent subclinical inflammation in sepsis complicates weaning from mechanical ventilation.
  • There is a need for biomarkers to accurately estimate septic burden and determine optimal weaning timing.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
513
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
227
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
190
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
133
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
373
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
417